For example, the treatment of mice with R-2-hydroxyglutarate (R-2HG), a FTO inhibitor, can inhibit FTO demethylase activity, thus increasing the overall m6A levels and leading to anti-tumor effects in vivo [151]. The gene discussed is FTO; the disease is neoplasm.